2021 tables: Institutions - life sciences - corporate

The 2021 tables are based on Nature Index data from 1 January 2020 to 31 December 2020.

Table criteria

# Institution Share 2019 Share 2020 Count 2020 Change in Adjusted Share 2019-2020*
1 Samsung Group, South Korea 2.55 2.43 29 -12.4%
2 Cellivery, South Korea 0.89 1 N/A
3 AmorePacific Corporation, South Korea 0.50 1 N/A
4 Clinomics Inc., South Korea 0.35 2 N/A
5 Il Yang Pharmaceutical Co. Ltd., South Korea 0.33 1 N/A
6 Theragen Etex Bio Institute, South Korea 0.02 0.32 2 1,124.9%
7 ExoStemTech Inc., South Korea 0.31 1 N/A
8 ILIAS Biologics Inc., South Korea 0.25 1 N/A
9 Tomocube, Inc., South Korea 0.20 2 N/A
10 Proteina Co Ltd., South Korea 0.20 1 N/A
10 SL BIGEN. Co., Ltd., South Korea 0.20 1 N/A
11 Green Cross Corporation, South Korea 0.19 2 N/A
12 Lemonex Inc., South Korea 0.18 1 N/A
13 CK Genomics, South Korea 0.16 1 N/A
14 Aventi Inc., South Korea 0.14 1 N/A
15 Novomics Co., Ltd., South Korea 0.14 1 N/A
16 MedPacto Inc., South Korea 0.13 2 N/A
17 JEUK Co., Ltd., South Korea 0.13 1 N/A
18 Macrogen Inc., South Korea 0.08 0.13 3 59.9%
19 Phyzen, South Korea 0.13 1 N/A
20 Orum Therapeutics Inc., South Korea 0.11 1 N/A
21 Biographene Inc., South Korea 0.10 1 N/A
22 TMD Lab, South Korea 0.09 2 N/A
23 IVIM Technology, South Korea 0.08 1 N/A
24 GNT Pharma Co., Ltd., South Korea 0.07 1 N/A
25 AmtixBio Co., Ltd., South Korea 0.07 1 N/A
26 GENOME INSIGHT, Inc., South Korea 0.07 2 N/A
27 Korea Mouse Phenotyping Center (KMPC), South Korea 0.19 0.06 2 -69.8%
28 Curocell Inc., South Korea 0.06 1 N/A
29 CK Biotechnology Inc., South Korea 0.06 1 N/A
29 Bio Imaging Korea Seoul, Co., Ltd., South Korea 0.06 1 N/A
30 Penta Medix Co., Ltd., South Korea 0.05 0.05 1 -8.1%
30 Hanwha Marine Biology Research Center, South Korea 0.05 1 N/A
31 Cell2in Co., Ltd., South Korea 0.05 1 N/A
32 GenoFocus Inc., South Korea 0.05 1 N/A
33 Seoul-Teracom, Inc., South Korea 0.04 1 N/A
34 LegoChemBio (LCB), South Korea 0.04 1 N/A
35 Bioway Inc., South Korea 0.04 1 N/A
36 ToolGen, Inc., South Korea 0.38 0.03 1 -92.4%
37 Syntekabio Inc., South Korea 0.03 4 N/A
38 NDBio Therapeutics Inc., South Korea 0.03 1 N/A
39 KoBioLabs, Inc., South Korea 0.09 0.02 1 -80.2%
40 Paean Biotechnology Inc., South Korea 0.01 1 N/A
41 PDXen Biosystems Inc., South Korea 0.01 4 N/A
42 National Health Insurance Service (NIHS), South Korea 0.00 0.00 1 -8.2%

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2020 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.